2026 - 2050 of 8571 Results
Title
Year
-
RESTRICTEDTitle: Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk FactorsJournal Name: Behavioral SciencesPublisher: MDPI AGVol: 11Issue #: 5Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/bs11050074Best OA location URL: https://www.mdpi.com/2076-328X/11/5/74/pdf?version=1621308905Citation Count: 45
-
RESTRICTEDTitle: Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with PathophysiologyJournal Name: AntioxidantsPublisher: MDPI AGVol: 12Issue #: 7Start Page: 1411End Page: 1411Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/antiox12071411Best OA location URL: https://www.mdpi.com/2076-3921/12/7/1411/pdf?version=1689141105Citation Count: 3
-
RESTRICTEDTitle: Proposal for a Biologic Staging System of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 13Issue #: 3Start Page: 297End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-225111Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd225111?id=journal-of-parkinsons-disease%2Fjpd225111Citation Count: 33
-
RESTRICTEDTitle: GBA1 and The Immune System: A Potential Role in Parkinson’s Disease?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: s1Start Page: S53End Page: S64Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223423Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223423?id=journal-of-parkinsons-disease%2Fjpd223423Citation Count: 5
-
RESTRICTEDTitle: The Role of Oxidative Stress in Parkinson's DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 3Issue #: 4Start Page: 461End Page: 491Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130230Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130230?id=journal-of-parkinsons-disease%2Fjpd130230Citation Count: 1321
-
RESTRICTEDTitle: The Role of Innate and Adaptive Immunity in Parkinson's DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 3Issue #: 4Start Page: 493End Page: 514Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130250Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130250?id=journal-of-parkinsons-disease%2Fjpd130250Citation Count: 262
-
RESTRICTEDTitle: Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory RoundtableJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 4Issue #: 4Start Page: 585End Page: 589Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140385Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140385?id=journal-of-parkinsons-disease%2Fjpd140385Citation Count: 16
-
RESTRICTEDTitle: Parkinson's Disease Mild Cognitive Impairment: Application and Validation of the CriteriaJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 4Issue #: 2Start Page: 131End Page: 137Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-130304Best OA location URL: https://escholarship.org/content/qt1525m3ww/qt1525m3ww.pdf?t=rtgk9lCitation Count: 54
-
RESTRICTEDTitle: LRRK2: Cause, Risk, and MechanismJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 3Issue #: 2Start Page: 85End Page: 103Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130192Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130192?id=journal-of-parkinsons-disease%2Fjpd130192Citation Count: 127
-
RESTRICTEDTitle: Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?Journal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 11Issue #: 9Start Page: 834End Page: 834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm11090834Best OA location URL: https://www.mdpi.com/2075-4426/11/9/834/pdf?version=1629944805Citation Count: 3
-
RESTRICTEDTitle: BIOLOGICAL AND COGNITIVE MARKERS OF PRESENILIN1 E280A AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: A COMPREHENSIVE REVIEW OF THE COLOMBIAN KINDREDJournal Name: The Journal Of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14283/jpad.2019.6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925534Citation Count: 37
-
RESTRICTEDTitle: Malevolent lurkers no more: NMDA receptors come of ageJournal Name: The Journal of PhysiologyPublisher: WileyVol: 575Issue #: 2Start Page: 317End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2006.114629Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1819446Citation Count: 6
-
RESTRICTEDTitle: Tardive Dyskinesia in Older Persons Taking AntipsychoticsJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 3127End Page: 3134Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s328301Best OA location URL: https://www.dovepress.com/getfile.php?fileID=74946Citation Count: 10
-
RESTRICTEDTitle: Levodopa-induced dyskinesia: a brief review of the ongoing clinical trialsJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 2Start Page: 51End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0051Citation Count: 3
-
RESTRICTEDTitle: Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinicJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0055Citation Count: 7
-
RESTRICTEDTitle: Infection and Risk of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 1Start Page: 31End Page: 43Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202279Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202279?id=journal-of-parkinsons-disease%2Fjpd202279Citation Count: 70
-
RESTRICTEDTitle: Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivityJournal Name: NeuroImagePublisher: Elsevier BVVol: 170Issue #:Start Page: 271End Page: 282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.015Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2016/11/03/062851.full.pdfCitation Count: 428
-
RESTRICTEDTitle: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline SummaryJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 20Start Page: 942End Page: 957Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868Best OA location URL: https://n.neurology.org/content/neurology/97/20/942.full.pdfCitation Count: 68
-
RESTRICTEDTitle: Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular ArchitectureJournal Name: NeuronPublisher: Elsevier BVVol: 96Issue #: 3Start Page: 651End Page: 666Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2017.09.055Best OA location URL: http://www.cell.com/article/S0896627317309248/pdfCitation Count: 388
-
RESTRICTEDTitle: The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 74End Page: 88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.049Best OA location URL: https://europepmc.org/articles/pmc4383729?pdf=renderCitation Count: 111
-
RESTRICTEDTitle: Therapy for Parkinson’s Disease: What is in the Pipeline?Journal Name: NeurotherapeuticsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0242-1Best OA location URL: https://europepmc.org/articles/pmc3899489?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxinsJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 563End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019Best OA location URL: https://europepmc.org/articles/pmc3200477?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Perspective on the current state of the LRRK2 fieldJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00544-7Best OA location URL: https://www.nature.com/articles/s41531-023-00544-7.pdfCitation Count: 11
-
RESTRICTEDTitle: Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00535-8Best OA location URL: https://www.nature.com/articles/s41531-023-00535-8.pdfCitation Count: 9
-
RESTRICTEDTitle: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00203-9Best OA location URL: https://www.nature.com/articles/s41531-021-00203-9.pdfCitation Count: 83